Secondary Prevention of Clostridioides Difficile Using Vancomycin | MicrobiomeTrials← Back to trialsNCT06979609
Secondary Prevention of Clostridioides Difficile Using Vancomycin
RecruitingPHASE2, PHASE3INTERVENTIONAL
Trial Details
Start: 2025-11-01Est. Completion: 2028-10-01
Enrollment target: 300 participants Locations- McGill University Health Centre, Montreal, Quebec, Canada
Other microbiome trials you might be interested in
Clostridium Difficile Infection
This is a Phase 1, first-in-human, double-blind, placebo-controlled, adaptive-design, single-site study, involving dose …
Knoxville, United StatesEst. completion Aug 22, 2028
Neutropenia, Febrile
The goal of this clinical trial is to compare a short course of antibiotics in patients in whom no bacterial infection i…
Leuven, BelgiumCompleted Mar 8, 2026
Phase 4
Recruiting
Blood Stream InfectionsVentilator Associated PneumoniaHealthcare Associated InfectionCarbapenem-Resistant Enterobacteriaceae InfectionHospital-acquired Pneumonia
RAPID is an investigator initiated Phase 4, multinational, multicentre, open-label, randomised controlled superiority tr…
Vellore, IndiaEst. completion Oct 31, 2027